Finance

Lists
Why is 009290 down 2,62%?
Dive Deeper
009290:KRX
Kwangdong Pharmaceutical Co Ltd
6 690,00 KRW
-2,62%
(-180,00) 1D
19 ოქტ, 11:44:37 GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 009290...
Open
6 760 KRW
High
6 840 KRW
Low
6 600 KRW
Mkt. cap
333,16 მლრ.
Avg. vol.
135,36 ათ.
Volume
108,80 ათ.
Dividend
1,49%
Quarterly dividend
25 KRW
Ex-dividend date
31 მარ. 2026
P/E ratio
13,15
52-wk high
12 800 KRW
52-wk low
5 150 KRW
EPS
509 KRW
Shares outstanding
49,80 მლნ.
No. of employees
1 ათ.
Open
6 760 KRW
High
6 840 KRW
Low
6 600 KRW
Mkt. cap
333,16 მლრ.
Avg. vol.
135,36 ათ.
Volume
108,80 ათ.
Dividend
1,49%
Quarterly dividend
25 KRW
Ex-dividend date
31 მარ. 2026
P/E ratio
13,15
52-wk high
12 800 KRW
52-wk low
5 150 KRW
EPS
509 KRW
Shares outstanding
49,80 მლნ.
No. of employees
1 ათ.
News stories
From web sources and news partners
Simply Wall Street
Simply Wall Street
·
25 წუთის წინ
What Viasat Doubters Got Wrong
Mitrade
Mitrade
·
8 წუთის წინ
Weekly Market Wrap: AI debt fears hit the Nasdaq as Brent pushes back above $100
The Fintech Times
The Fintech Times
·
1 საათის წინ
First Digital to List on Nasdaq via SPAC Deal at $250m Valuation
Bloomberg.com
Bloomberg.com
·
4 საათის წინ
US Stock Futures Rise Ahead of Busy Earnings Week: Markets Wrap
About Kwangdong Pharmaceutical Co Ltd
CEOსეონგ ვონ ჩო
Employees1 ათ.
Founded1963
Headquarters-
SectorPharmaceutical industry
Websiteekdp.com
Previous reportsAll values in KRW
Loading Previous Earnings...
Revenue
Net income
All values in KRW
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
444,52 მლრ.
412,10 მლრ.
410,85 მლრ.
439,82 მლრ.
Cost of goods sold
364,37 მლრ.
331,32 მლრ.
336,56 მლრ.
363,42 მლრ.
Cost of revenue
364,37 მლრ.
331,32 მლრ.
336,56 მლრ.
363,42 მლრ.
Research and development expenses
2,31 მლრდ.
2,52 მლრდ.
3,02 მლრდ.
2,72 მლრდ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
64,25 მლრდ.
63,37 მლრდ.
59,62 მლრდ.
68,37 მლრდ.
Operating expense
69,28 მლრდ.
68,45 მლრდ.
66,77 მლრდ.
73,58 მლრდ.
Total operating expenses
433,65 მლრ.
399,77 მლრ.
403,33 მლრ.
436,99 მლრ.
Operating income
10,87 მლრდ.
12,33 მლრდ.
7,52 მლრდ.
2,82 მლრდ.
Other non operating income
163,53 მლნ.
474,20 მლნ.
-904,17 მლნ.
163,97 მლნ.
EBT including unusual items
14,32 მლრდ.
7,59 მლრდ.
6,56 მლრდ.
4,44 მლრდ.
EBT excluding unusual items
10,58 მლრდ.
4,88 მლრდ.
8,31 მლრდ.
2,54 მლრდ.
Income tax expense
3,21 მლრდ.
3,82 მლრდ.
1,66 მლრდ.
1,28 მლრდ.
Effective tax rate
22,45%
50,37%
25,29%
28,78%
Other operating expenses
503,83 მლნ.
440,15 მლნ.
516,85 მლნ.
310,45 მლნ.
Net income
10,79 მლრდ.
3,93 მლრდ.
4,40 მლრდ.
2,71 მლრდ.
Net profit margin
2,43%
0,95%
1,07%
0,62%
Earnings per share
-
-
-
-
Interest and investment income
1,50 მლრდ.
1,31 მლრდ.
1,85 მლრდ.
1,87 მლრდ.
Interest expense
-2,64 მლრდ.
-2,69 მლრდ.
-2,97 მლრდ.
-3,08 მლრდ.
Net interest expenses
-1,15 მლრდ.
-1,38 მლრდ.
-1,12 მლრდ.
-1,21 მლრდ.
Depreciation and amortization charges
1,66 მლრდ.
1,75 მლრდ.
1,90 მლრდ.
1,89 მლრდ.
EBITDA
15,46 მლრდ.
17,02 მლრდ.
13,15 მლრდ.
8,44 მლრდ.
Gain or loss from assets sale
-517,21 მლნ.
-156,85 მლნ.
-77,73 მლნ.
-134,74 მლნ.
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები